NCT02182245View on ClinicalTrials.gov

Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 1, 2005

Primary Completion Date

January 1, 2007

Conditions
Genital Neoplasms, Female
Interventions
DRUG

BIBF 1120

DRUG

Paclitaxel

DRUG

Carboplatin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY